शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ALBERTDAVDBSEAlbert David Ltd-$· Pharmaceuticals & BiotechnologyCriticalNegative
Announced Fri, 19 Dec, 2025 · 16:31 IST

Resignation of Mr. Umesh Manohar Kunte as Director w.e.f 18-12-2025.

CEO resignedKey managerial personnel resignedManagement Changes View source PDFExplain this filing

ALBERTDAVD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.1%Reaction day
₹743.10
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.4%-0.3% vs market
Pharmaceuticals peers, median of 155sector+0.7%+0.4% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.1+1.4-0.3+0.7+0.4
Next day
+0.9+1.4-0.5+0.6+0.3
2d
+0.9+0.9+0.1+0.6+0.3
3d
+1.1+0.3+0.7+0.0+1.0
4d
-0.4-0.4+0.0-0.7+0.3
5d
-0.8-0.5-0.3-0.8+0.0
1w
-0.0+1.1-1.1+0.1-0.1
15d
-1.5-2.5+1.0-2.1+0.6
1m
-7.8-6.1-1.7-5.9-1.9
2m
-3.2-2.8-0.4-5.6+2.4
3m
-14.0-14.9+0.9-13.4-0.6
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 155Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Umesh Manohar Kunte (DIN: 03398438) has resigned from the board of Albert David Ltd, stepping down as Managing Director, Chief Executive Officer, and Director effective from the close of business hours on 18 December 2025. The reason cited is personal reasons and priorities, and he has also given a three-month notice period in his resignation letter. The Board accepted his resignation at its meeting held on 18 December 2025 and recorded appreciation for his contributions. With this exit, Mr. Kunte will also cease to be a Key Managerial Person (KMP) of the company under Section 203 of the Companies Act, 2013.

Likely market impact

The sudden exit of the top leadership (MD & CEO) of a single MD-led company may create short-term uncertainty around strategy and continuity, which investors should monitor. Watch for an announcement regarding the appointment of a new MD/CEO, as the lack of a successor plan could weigh on sentiment.